ROCKWELL MEDICAL, INC. Finance Lease, Liability, to be Paid, Year Two
ROCKWELL MEDICAL, INC. (RMTI) had Finance Lease, Liability, to be Paid, Year Two of $0 as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Commitment and Contingencies › Finance Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo · last filed 2026-08-13
- 2026-06-30: Finance Lease, Liability, to be Paid, Year Two $0.00.
- 2026-03-31: Finance Lease, Liability, to be Paid, Year Two $0.00.
- 2025-12-31: Finance Lease, Liability, to be Paid, Year Two $311.00K.
- 2025-09-30: Finance Lease, Liability, to be Paid, Year Two $311.00K.
| Period end | Finance Lease, Liability, to be Paid, Year Two |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 |
| 2025-12-31 | $311.00K 10-K · filed 2026-03-26 |
| 2025-09-30 | $311.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $311.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $311.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $666.00K 10-K · filed 2025-03-20 |
| 2024-09-30 | $666.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $666.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $666.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $676.00K 10-K · filed 2024-03-21 |
| 2023-09-30 | $676.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $676.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $676.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $672.00K 10-K · filed 2023-03-30 |
| 2022-09-30 | $672.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $672.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $672.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $668.00K 10-K · filed 2022-04-08 |
| 2021-09-30 | $424.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $305.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $272.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $179.00K 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |